Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |